KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Asset Utilization Ratio (2016 - 2025)

Neogenomics' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.53 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 32.03% year-over-year to 0.53; the TTM value through Dec 2025 reached 0.53, up 32.03%, while the annual FY2025 figure was 0.49, 21.91% up from the prior year.
  • Asset Utilization Ratio reached 0.53 in Q4 2025 per NEO's latest filing, up from 0.51 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.6 in Q1 2021 to a low of 0.25 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.36, with a median of 0.35 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 71.59% in 2021, then surged 32.03% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.26 in 2021, then grew by 13.69% to 0.29 in 2022, then increased by 20.77% to 0.35 in 2023, then rose by 14.38% to 0.4 in 2024, then soared by 32.03% to 0.53 in 2025.
  • Per Business Quant, the three most recent readings for NEO's Asset Utilization Ratio are 0.53 (Q4 2025), 0.51 (Q3 2025), and 0.46 (Q2 2025).